It's not about us. It's about the patients. Tom Baker explains how IQVIA consultants help our customers tackle healthcare's most complex challenges. Find your fit with us: https://bit.ly/4yxs5Da #WeAreIQVIA
About us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
Get directions
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
Scaling scientific inquiry as source information grows and fragments is possible with IQVIA AI Scientific Navigator—an AI-ready content foundation built on 100s of millions of centralized scientific documents, extensible to any other sources. Join IQVIA Applied AI Science’s Sarah Lyons, Head of Operations, and Paul Milligan, Director of Product Strategy, on August 6 at 10 am ET for a presentation, demo and live Q&A. Register here: https://bit.ly/4wgBdL4
-
-
What does it takes to turn patient experience data into reliable, predictive insight? Read Lindsay Hughes’ new article to learn how AI and machine learning models can move beyond describing what has occurred to anticipating where risk will emerge, including identifying patients who may disengage and flagging sites that show early signals of data quality issues. https://bit.ly/4vy05N9
-
-
AI is no longer experimental. The challenge is scaling it with confidence. Hear from Tom Baker on why this matters for healthcare and life sciences leaders, and what it takes to move from AI potential to real-world impact. Be part of the conversation at IQVIA TechIQ 2026 in Boston on October 7-8 and learn how organizations are putting AI and data to work across the enterprise. Reserve your spot today: https://bit.ly/4ahwKPf
-
We are proud to be named a 2026 Best Company to Work For by U.S. News & World Report. Curious what sets IQVIA apart? Read the blog: https://bit.ly/3QX82xl #WeAreIQVIA
-
-
Real-world evidence is increasingly shaping how companies differentiate, launch, and sustain value throughout the product lifecycle. Our latest analysis explores how evidence strategies are evolving and what that means for future competitive advantage. Read now https://bit.ly/3Rwn9hk
-
With MFN pricing at the centre of global pharmaceutical policy debate, we examine whether recent declines in European innovative medicine launches are signal or noise. https://bit.ly/4aYbheH
-
-
The biggest healthcare challenges can't be solved in silos. Rob Kotchie, president, Real World Evidence & Clinical Technology Solutions, shares why collaboration is one of IQVIA's greatest strengths. Learn more about our culture: https://bit.ly/44pyfHU #WeAreIQVIA
-
Explore how disease modifying therapies, blood-based biomarkers and digital technologies are reshaping Alzheimer’s care. Learn more about innovations and new diagnostics that help with earlier identification and proactive management, and what healthcare systems need to do to prepare. Read the blog: https://bit.ly/4yoL82O
-
-
Bonjour! Ana is back to take us inside the IQVIA Paris office, including the little touches that make this location très special. Inspired? Find your place at IQVIA: https://bit.ly/4wVMFvJ #WeAreIQVIA